APPLY: ERDERA Networking Support Scheme (NSS) funding call

The European Rare Diseases Research Alliance (ERDERA) has a call for the Networking Support Scheme (NSS). The deadline for this round of funding is open until early October. The aim of the NSS is to bring rare disease and the rare cancer community together across borders, disciplines and sectors.

This call will be open until April 2029 with applications
being reviewed on a six-monthly basis.

APPLY:

Clinical Exchange Programme

The Endo-ERN Clinical Exchange Programme is now open! We encourage you to share this opportunity within your team and inspire colleagues to apply. The programme offers rich opportunities to gain experience, share expertise, and strengthen collaboration across the network.

Several centres have already prepared exchange plans — check out the host page for ideas — but remember that exchanges are possible between any Endo-ERN members. The call for applications is open 1 October – 30 November, 2025.

If you are interested in hosting please email the Project Office.

ATTEND FREE:

World Orphan Drug Congress Europe 2025

Endo-ERN is proud to partner with the World Orphan Drug Congress Europe 2025 happening 27-29 October in Amsterdam. This is the meeting place for the rare disease community:

• 250+ international speakers from academia, pharma, policy, and patient advocacy

10 content tracks & 5 keynotes on regulation, gene & cell therapy, access, and innovation

2,000+ attendees ready to connect and collaborate

As an Endo-ERN member, you can apply for a free VIP pass to join the conversation and network with leaders shaping the future of rare disease therapies.

REGISTER:

Functioning Neuroendocrine Tumour Syndromes: Biochemical, Genetic, Imaging Workup & Therapeutic Management

Discover the latest in neuroendocrine tumour care at this intensive 3-day course, hosted in Milan, Italy, 6-8 November – bringing together global experts and interactive workshops.

Highlights include:

Foundations & Evolution: From history of NETs (Wouter de Herder, NL) to pathology outlines (Federica Grillo, IT)

Functioning Syndromes & Genetics: Insulinoma, carcinoid syndrome, and genetic syndromes in pancreatic NETs (Christ, Panzuto, Newey)

Cutting-Edge Imaging: EUS, MRI/CT, and nuclear medicine insights from leading specialists

Therapeutic Strategies: Somatostatin analogs, radioligand therapy, targeted treatments, and sequencing workshops

Looking Ahead: Future perspectives (Simron Singh, CA) and the vital role of patient support groups (Mark McDonnell, IE)

With expert faculty from across Europe and beyond, this course blends lectures, case studies, and interactive workshops to deepen knowledge and sharpen practice.